ADPD 2023: Alzheimer's Disease Therapeutics, Diagnostics & Mechanisms
An App knock-in rat model for Alzheimer's disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments | Cell Research
IJMS | Free Full-Text | CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease
Amyloid β-based therapy for Alzheimer's disease: challenges, successes and future | Signal Transduction and Targeted Therapy
Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre‐clinical AD, amnestic mild cognitive impairment and late‐stage AD - Tramutola - 2015 -
Decreased salivary lactoferrin levels are specific to Alzheimer's disease - eBioMedicine
Association of B cell profile and receptor repertoire with the progression of Alzheimer's disease - ScienceDirect
Synergistic Association between Plasma Aβ1–42 and p-tau in Alzheimer's Disease but Not in Parkinson's Disease or Frontotemporal Dementia | ACS Chemical Neuroscience
IJMS | Free Full-Text | Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment
Amyloid‐β oligomers in cellular models of Alzheimer's disease - Fontana - 2020 - Journal of Neurochemistry - Wiley Online Library
Frontiers | Bridging the Gap Between Fluid Biomarkers for Alzheimer's Disease, Model Systems, and Patients
Amyloid blood biomarker detects Alzheimer's disease | EMBO Molecular Medicine
Pyroglutamate Aβ cascade as drug target in Alzheimer's disease | Molecular Psychiatry
Blood‐based biomarkers for Alzheimer's disease | EMBO Molecular Medicine
Nasal administration of anti-CD3 monoclonal antibody ameliorates disease in a mouse model of Alzheimer's disease | PNAS
Structural Dynamics of Amyloid-β Protofibrils and Actions of Anti-Amyloid-β Antibodies as Observed by High-Speed Atomic Force Microscopy | Nano Letters
Frontiers | Alzheimer's disease: a mini-review for the clinician
Frontiers | Manipulation of the diet–microbiota–brain axis in Alzheimer's disease
Identifying and validating biomarkers for Alzheimer's disease: Trends in Biotechnology
Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer's disease | Translational Psychiatry
